CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net Income (Loss)	$ (5,747)	$ (9,498)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,426	986
Stock-based compensation expense	1,951	2,955
Credit loss, net of recoveries	508	2,767
(Gain) loss on disposition of assets	(2)	61
Noncash amortization of debt discount	584	546
Noncash change in fair value of derivatives	(56)	(309)
Other	(2)	0
Changes in operating assets and liabilities:
Accounts receivable	554	(2,104)
Prepaid expenses and other current assets	1,801	825
Accounts payable	(128)	(813)
Accrued expenses and other current liabilities	682	(3,826)
Deferred revenue	(246)	(194)
Net cash provided by (used in) operating activities	1,325	(8,604)
Cash flows from investing activities
Additions of property, equipment, and software	(1,465)	(1,345)
Proceeds from sale of property and equipment	2	29
Net cash used in investing activities	(1,463)	(1,316)
Cash flows from financing activities
Issuance of common stock under ESPP	24	168
Tax payments related to shares retired for vested restricted stock units	(79)	0
(Repayments of) advances from related party payables	(90)	94
Net proceeds from sale of stock via ATM Offering	908	0
Repayments of short-term financing arrangements	(1,397)	0
Net cash (used in) provided by financing activities	(634)	262
Net decrease in cash, cash equivalents, and restricted cash	(772)	(9,658)
Cash, cash equivalents, and restricted cash, beginning of year	15,544	25,202
Cash, cash equivalents, and restricted cash, end of year	14,772	15,544
Supplemental disclosure of non-cash financing activities
Short-term financing of insurance payable	1,399	0
Conversion of promissory notes into common stock	$ 292	$ 0